Acurx Pharmaceuticals, Inc.
NASDAQ:ACXP
0.3728 (USD) • At close April 17, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Operating Activities: | ||||||
| Net Income
| -14,103.103 | -14.578 | -12.093 | -12.748 | -4.6 | -5.931 |
| Depreciation & Amortization
| 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Income Tax
| 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 2,601.903 | 3.766 | 3.302 | 6.742 | 1.268 | 0.9 |
| Change In Working Capital
| 0.284 | 0.03 | 1.248 | 0.141 | -0.801 | 1.046 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 0 | 0 | 1.218 | 387.978 | 0 | 0 |
| Other Working Capital
| 0.284 | 0.03 | 0.03 | -387.837 | -0.801 | 1.046 |
| Other Non Cash Items
| 1,117.485 | 0.981 | 3.302 | 0.85 | 0.782 | 0.9 |
| Operating Cash Flow
| -10,383.431 | -9.801 | -7.542 | -5.014 | -3.352 | -3.985 |
| Investing Activities: | ||||||
| Investments In Property Plant And Equipment
| 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow
| 0 | 0 | 0 | 0 | 0 | 0 |
| Financing Activities: | ||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0.067 | 0 |
| Common Stock Issued
| 6.406 | 5.944 | 3.695 | 14.797 | 3.977 | 4.455 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 6,609.55 | 2.219 | 0 | 0 | 0 | 0 |
| Financing Cash Flow
| 6,615.956 | 8.163 | 3.695 | 14.797 | 4.044 | 4.455 |
| Other Information: | ||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -3,767.475 | -1.638 | -3.847 | 9.783 | 0.692 | 0.47 |
| Cash At End Of Period
| 3,706.713 | 7.474 | 9.112 | 12.959 | 3.175 | 2.483 |